Graciela González-Pérez, Jorge Román Corona-Rivera, Lucina Bobadilla-Morales, Alfredo Corona-Rivera, Sinhue Alejandro Brukman-Jiménez, José de Jesús Pérez-Becerra, Víctor Ulises Rodríguez-Machuca, María Teresa Alejandra González-Rodríguez, Juan Antonio Ramirez-Corona, Idalid Cuero-Quezada, Xóchitl Aurora Ramírez-Urenda, Felipe de Jesús Bustos-Rodríguez
Journal: International journal of molecular sciences 2024;25(22):
PMID: 39596402
Variants in the gene are associated with retinoblastoma (RB) development, and their presence in germline cells considerably increases the risk of subsequent malignant neoplasms (SMNs) in RB survivors. We report a female patient with bilateral RB who developed two SMNs in less than ten years, with a de novo pathogenic nonsense variant in [NM_000321.3:c.306T>A, p.(Cys102*)] in heterozygosity. The updated literature review of similar cases of SMN in patients with a previous diagnosis of RB reveals a wide range in both the type of subsequent malignancy and the age at which these SMNs develop. In addition, we identified only three cases with two SMNs following RB diagnosis, with at least one of these being an EWS. This case broadens the clinical and genetic landscape of RB, demonstrates the importance of a multidisciplinary approach in these patients, and highlights genetic diagnosis as a mandatory feature for management.
Full Text Sources:
Miscellaneous:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.